2. Dissolution
Dissolution is the process by which a solid solute enters in to a solution i.e. , mass transfer from
solid surface to liquid phase.
Dissolution tests
Dissolution testing measures the extent and rate of solution formation from a dosage form, such
as tablet, capsule, ointment, etc. The dissolution of a drug is important for its bioavailability and
therapeutic effectiveness.
3. Difference Between Drug Release &
Dissolution
Dissolution test is normally used to describe the testing of those forms such as immediate
release oral tablets or capsules intended to dissolve rapidly in the test medium.
For non-oral dosage forms such as semisolids, suppositories, topical and transdermal systems,
the term “drug release” is normally employed.
4. What is the Dissolution Apparatus ?
Tablet Dissolution is a standardized method for measuring the rate of drug release from a
dosage form
In the pharmaceutical industry, drug dissolution testing is routinely used to provide critical in
vitro drug release information for both quality control purposes, i.e., to assess batch-to-batch
consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict in
vivo drug release profiles.
5. Purposes of Dissolution Apparatus
Test
1. Quality-control and quality-assurance purposes
2. In early phase drug development.
3. Assess product stability, monitor formulation changes over time.
4. Establish in-vitro–in-vivo correlations "IVIVC"
5. Regulatory perspective Particularly in the development and approval of generic
dosage forms
6.
7. Rotating Basket Apparatus
(Apparatus 1)
basically a closed-compartment beaker type apparatus
comprising of a cylindrical glass vessel with hemispherical
bottom of one liter capacity partially immersed in a water
bath to maintain the temperature at 37oC.
A cylindrical basket made of 22 mesh to hold the dosage form
is located centrally in the vessel at a distance of 2 cm from the
bottom and rotated by a variable speed motor through a shaft
The basket should remain in motion during drawing of
samples. All metal parts like basket and shaft are made of SS
316.
8. Rotating Paddle Apparatus
(Apparatus 2)
the rotating basket is replaced with a paddle which acts as a
stirrer
The dosage form is allowed to sink to the bottom of the
vessel.
Sinkers are recommended to prevent floating of capsules and
other floatable forms.
A small, loose, wire helix may be attached to such
preparations to prevent them from floating.
9. Reciprocating Cylinder
Apparatus (Apparatus 3)
This apparatus consists of a set of cylindrical flat-
bottomed glass vessels equipped with
reciprocating cylinders
The apparatus is particularly used for dissolution
testing of controlled release bead-type (pellet)
formulations.
10. Flow-Through Cell Apparatus
(Apparatus 4)
consists of a reservoir for the dissolution medium and a pump that
forces dissolution medium through the cell holding the test sample.
It may be used in either – Closed-mode where the fluid is recirculated
and, by necessity, is of fixed volume, or Open-mode when there is
continuous replenishment of the fluids.
The material under test (tablet, capsules, or granules) is placed in the
vertically mounted dissolution cell, which permits fresh solvent to be
pumped (between 240 and 960 mL/h) in from the bottom
Advantages of this apparatus include –
1. Easy maintenance of sink conditions for dissolution which is often
required for drugs having limited aqueous solubility.
2. Feasibility of using large volume of dissolution fluid.
3. Feasibility for automation of apparatus
11. Paddle Over Disc Apparatus
(Apparatus 5)
used for evaluation of transdermal products and consists of a
sample holder or disc that holds the product.
The disc is placed at the bottom of apparatus and the
apparatus operated in the usual way.
12. Cylinder Apparatus
(Apparatus 6)
Used for evaluation of transdermal products and is
similar to apparatus 1
Instead of basket, a stainless steel cylinder is used to
hold the sample.
The sample is mounted on an inert porous cellulosic
material and adhered to the cylinder.
13. Reciprocating Disc Apparatus
(Apparatus 7)
Used for evaluation of transdermal products as well as non
disintegrating controlled-release oral preparations.
The samples are placed on disc-shaped holders using inert
porous cellulosic support which reciprocates vertically by means
of a drive inside a glass container containing dissolution
medium.
The test is carried out at 320C and reciprocating frequency of 30
cycles/min
14. Dissolution test
The test is designed to determine compliance with the dissolution requirements for
solid dosage forms administered orally.
Place the stated volume of the dissolution medium free from dissolved air into the
vessel of the apparatus.
Assemble the apparatus and warm the dissolution medium to 36.5 degree to 37.5
degree.
Unless otherwise stated place one dosage unit in the apparatus taking care to exclude
air bubbles from the surface of the dosage unit.
For each of the tablet calculate the amount of dissolved active ingredient in solution as
a percentage of the stated amount.
Conventional-release dosage form.
Unless otherwise specified the requirements are met if the quantities of active
substance dissolved from the dosage units confirm to table1.
If the results do not conform to the requirements as given in the table continue testing
with additional dosage units through s2 and s3 unless the results confirm at stage 2.
15. *D is the amount of dissolved active ingredient specified in the individual monograph,
expressed as percentage of labelled content
**percentage of labelled content
Level Number
tested
Acceptance criteria
S1 6 Each unit is less than D*+ 5%**
S2 6 Average of 12 units ( S1 + S2) is equal
to or greater than D and no unit is less
than D-15%**
S3 12 Average of 24 units (S1 + S2 + S3) is
equal to or greater than D not more
than 2 units are less than D-15%** and
no unit is less than D-25%**